Validation of Medios AI, an Automated Artificial intelligence Glaucoma Screening Tool, on a Smartphone Based Fundus Camera in real world setting

Not Applicable

Conditions: Health Condition 1: H406- Glaucoma secondary to drugsHealth Condition 2: H403- Glaucoma secondary to eye traumaHealth Condition 3: H405- Glaucoma secondary to other eye disordersHealth Condition 4: H400- Glaucoma suspectHealth Condition 5: H401- Open-angle glaucomaHealth Condition 6: H402- Primary angle-closure glaucoma

Registration Number: CTRI/2021/07/035145

Lead Sponsor: Remidio Innovative Solutions Pvt Ltd

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1. Glaucoma Group:Any case of glaucoma with typical glaucomatous disc changes, confirmed by clinical evaluation and visual field test (primary open angle glaucoma(POAG), normal tension glaucoma (NTG), primary angle closure glaucoma (PACG), secondary glaucomas)

2.Normal Controls (including Ocular hypertension (OHT) and primary angle closure suspects (PACS) status post laser peripheral iridotomy (LPI))

3.Disc suspects

4.Reliable Visual field (false positive (FP), false negative (FN) <20%)

Exclusion Criteria

1.Patient with acute or sudden vision loss

2.Patient deemed to have narrow angles on gonioscopy and cannot be dilated (primary angle closure)

3.Co-existing retinal pathologies precluding view of disc including Proliferative diabetic retinopathy

4.Significant media opacity precluding adequate view of the disc

5. Participant has a condition that, in the opinion of the investigator, would preclude participation in the study (e.g., uncontrolled intraocular pressure, active eye infection, <3 months post- glaucoma filtering surgery, unstable medical status including blood pressure or glycemic control).

6.Participant is contraindicated for imaging by fundus imaging systems used in the study:

a.Participant is hypersensitive to light

b.Participant recently underwent photodynamic therapy (PDT)

c.Participant is photosensitive or is consuming medication that causes photosensitivity.